These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32948398)

  • 21. Diabetic gastroparesis.
    Koch KL; Calles-Escandón J
    Gastroenterol Clin North Am; 2015 Mar; 44(1):39-57. PubMed ID: 25667022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A ghrelin agonist fails to show benefit in patients with diabetic gastroparesis: let's not throw the baby out with the bath water.
    Camilleri M; Acosta A
    Neurogastroenterol Motil; 2013 Nov; 25(11):859-63. PubMed ID: 24001134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastroparesis in Adolescent Patient with Type 1 Diabetes: Severe Presentation of a Rare Pediatric Complication.
    Lombardo F; Bombaci B; Costa S; Valenzise M; Giannitto N; Cardile D; Baldari S; Salzano G; Passanisi S
    J Clin Res Pediatr Endocrinol; 2024 Mar; 16(1):111-115. PubMed ID: 36047486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prucalopride in diabetic and connective tissue disease-related gastroparesis: Randomized placebo-controlled crossover pilot trial.
    Andrews CN; Woo M; Buresi M; Curley M; Gupta M; Tack J; Wilsack L; Nasser Y
    Neurogastroenterol Motil; 2021 Jan; 33(1):e13958. PubMed ID: 32743954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Investigation and Treatment of Diabetic Gastroparesis.
    Kumar M; Chapman A; Javed S; Alam U; Malik RA; Azmi S
    Clin Ther; 2018 Jun; 40(6):850-861. PubMed ID: 29748143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis.
    McCallum RW; Lembo A; Esfandyari T; Bhandari BR; Ejskjaer N; Cosentino C; Helton N; Mondou E; Quinn J; Rousseau F;
    Neurogastroenterol Motil; 2013 Nov; 25(11):e705-17. PubMed ID: 23848826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nutrition therapy for diabetic gastroparesis.
    Gentilcore D; O'Donovan D; Jones KL; Horowitz M
    Curr Diab Rep; 2003 Oct; 3(5):418-26. PubMed ID: 12975033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis.
    Ordög T; Takayama I; Cheung WK; Ward SM; Sanders KM
    Diabetes; 2000 Oct; 49(10):1731-9. PubMed ID: 11016458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional Imaging of Evaluation of Diabetic Gastroparesis.
    Santhanam P; Marashdeh W; Solnes L
    Curr Diabetes Rev; 2018; 14(3):222-226. PubMed ID: 28128051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practical management approach to gastroparesis.
    Longley KJ; Ho V
    Intern Med J; 2020 Aug; 50(8):909-917. PubMed ID: 31314176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastric electrical stimulation for the treatment of diabetic gastroparesis.
    Guerci B; Bourgeois C; Bresler L; Scherrer ML; Böhme P
    Diabetes Metab; 2012 Nov; 38(5):393-402. PubMed ID: 22742875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic applications of ghrelin agonists in the treatment of gastroparesis.
    Shin A; Wo JM
    Curr Gastroenterol Rep; 2015 Feb; 17(2):430. PubMed ID: 25702264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis.
    Erbas T; Varoglu E; Erbas B; Tastekin G; Akalin S
    Diabetes Care; 1993 Nov; 16(11):1511-4. PubMed ID: 8299441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of metoclopramide in diabetic gastroparesis.
    Ricci DA; Saltzman MB; Meyer C; Callachan C; McCallum RW
    J Clin Gastroenterol; 1985 Feb; 7(1):25-32. PubMed ID: 3884697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic gastroparesis: diagnosis and management.
    Ma J; Rayner CK; Jones KL; Horowitz M
    Drugs; 2009 May; 69(8):971-86. PubMed ID: 19496627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic effects of ghrelin and growth hormone releasing peptide 6 on gastroparesis in streptozotocin-induced diabetic guinea pigs in vivo and in vitro.
    Qiu WC; Wang ZG; Wang WG; Yan J; Zheng Q
    Chin Med J (Engl); 2008 Jul; 121(13):1183-8. PubMed ID: 18710636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of Ghrelin Agonists in Patients with Diabetic Gastroparesis: A Systematic Review and Meta-Analysis.
    Hong SW; Chun J; Kim J; Lee J; Lee HJ; Chung H; Cho SJ; Im JP; Kim SG; Kim JS
    Gut Liver; 2020 Sep; 14(5):589-600. PubMed ID: 31816671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes and the Stomach.
    Lee AA; Hasler WL
    Curr Treat Options Gastroenterol; 2017 Dec; 15(4):441-459. PubMed ID: 28879488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of diabetic gastroparesis.
    Aljarallah BM
    Saudi J Gastroenterol; 2011; 17(2):97-104. PubMed ID: 21372345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastroparesis: New insights into an old disease.
    Usai-Satta P; Bellini M; Morelli O; Geri F; Lai M; Bassotti G
    World J Gastroenterol; 2020 May; 26(19):2333-2348. PubMed ID: 32476797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.